SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 115 filers reported holding SUTRO BIOPHARMA INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,920,696 | -30.4% | 1,129,823 | -6.8% | 0.00% | -50.0% |
| Q2 2023 | $5,634,815 | +4.0% | 1,211,788 | +3.3% | 0.00% | 0.0% |
| Q1 2023 | $5,419,886 | +100417.2% | 1,173,199 | +75.7% | 0.00% | 0.0% |
| Q4 2022 | $5,392 | -99.8% | 667,543 | +46.2% | 0.00% | +100.0% |
| Q3 2022 | $2,534,000 | +33.7% | 456,583 | +25.6% | 0.00% | 0.0% |
| Q2 2022 | $1,895,000 | -48.4% | 363,645 | -18.6% | 0.00% | 0.0% |
| Q1 2022 | $3,674,000 | -31.6% | 446,955 | +23.9% | 0.00% | -50.0% |
| Q4 2021 | $5,369,000 | +13.2% | 360,765 | +43.7% | 0.00% | 0.0% |
| Q3 2021 | $4,742,000 | -24.6% | 251,081 | -25.8% | 0.00% | 0.0% |
| Q2 2021 | $6,287,000 | -23.6% | 338,187 | -6.6% | 0.00% | -33.3% |
| Q1 2021 | $8,229,000 | +284.5% | 362,177 | +267.5% | 0.00% | +200.0% |
| Q4 2020 | $2,140,000 | – | 98,551 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,675,579 | $5,814,259 | 1.78% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 5,883,693 | $20,416,415 | 1.10% |
| Kynam Capital Management, LP | 1,552,675 | $5,387,782 | 0.88% |
| Parkman Healthcare Partners LLC | 1,182,168 | $4,102,123 | 0.75% |
| Rubric Capital Management LP | 3,344,810 | $11,606,491 | 0.44% |
| BVF INC/IL | 3,347,946 | $11,617,373 | 0.31% |
| DAFNA Capital Management LLC | 283,079 | $982,284 | 0.31% |
| SECTORAL ASSET MANAGEMENT INC | 432,339 | $1,500,216 | 0.29% |
| Eversept Partners, LP | 769,638 | $2,670,644 | 0.23% |
| Frazier Life Sciences Management, L.P. | 780,000 | $2,706,600 | 0.18% |